Cardiac dysfunction in patients treated for cancer: a challenge to cardiologists
DOI:
https://doi.org/10.24170/23-1-7813Abstract
The rapid and extensive development of numerous cancer therapies has led to greatly improved patient survival. In parallel with greater survivorship, the incidence of cancer therapy-related cardiac disease (CTRCD) has increased. Therefore, it behoves cardiologists to anticipate the many manifestations of CTRCD, requiring awareness of the nature and extent of the cancer, its genetic type, detailed insight into the treatment to be applied or already given, its possible side effects, and the intrinsic risk to the patient’s cardiovascular health at baseline.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 SA Heart Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This journal is an open access journal, and the authors and journal should be properly acknowledged, when works are cited.
Authors may use the publishers version for teaching purposes, in books, theses, dissertations, conferences and conference papers.
A copy of the authors’ publishers version may also be hosted on the following websites:
- Non-commercial personal homepage or blog.
- Institutional webpage.
- Authors Institutional Repository.
The following notice should accompany such a posting on the website: “This is an electronic version of an article published in SAHJ, Volume XXX, number XXX, pages XXX–XXX”, DOI. Authors should also supply a hyperlink to the original paper or indicate where the original paper (http://www.journals.ac.za/index.php/SAHJ) may be found.
Authors publishers version, affiliated with the Stellenbosch University will be automatically deposited in the University’s’ Institutional Repository SUNScholar.
Articles as a whole, may not be re-published with another journal.
Copyright Holder: SA Heart Journal
The following license applies:
Attribution CC BY-NC-ND 4.0
